The Nucleic Acid Standards for Biosecurity Act requires the National Institute of Standards and Technology (NIST) to create best practices and standards for the synthesis of nucleic acids, which are essential for developing medicines and agricultural products. This bill aims to prevent the misuse of this technology, which could lead to the creation of harmful biological agents. NIST will conduct research, engage with stakeholders, and report findings to Congress on how to improve safety and security in nucleic acid synthesis, especially in relation to artificial intelligence.
The bill has been positively received as a proactive measure to enhance biosecurity in the field of genetic engineering. Supporters highlight its importance in preventing potential bioterrorism and ensuring that advancements in synthetic biology are accompanied by robust safety standards. The emphasis on stakeholder engagement is seen as a way to foster collaboration among scientists, industry leaders, and policymakers.
Critics argue that the bill may not go far enough to address the rapid advancements in genetic synthesis technology and the potential risks associated with it. Some media outlets have expressed concerns that the focus on standards could slow down innovation in the biotech sector, potentially hindering beneficial research and development. There are also worries about the adequacy of NIST's resources to effectively implement the requirements of the bill.
The Nucleic Acid Standards for Biosecurity Act, sponsored by Andrea Salinas, does not show any direct industry overlaps with her top donor industries, which are primarily health professionals and retirees. The total contributions from these sectors amount to $315 million, with no evident ties to the biosecurity or nucleic acid sectors. While there is significant lobbying activity in the policy area, the amounts from these entities do not directly correlate with Salinas's financial backers. For instance, major lobbying contributions include $50,000 from Everyrealm Inc. and $50,000 from Constellium Rolled Products Ravenswood, LLC, but these do not connect to Salinas's top donor industries. Thus, the potential for conflicts of interest appears minimal, as the financial interests of her donors do not align with the bill's subject matter.
Organizations that lobbied on issues related to this bill's policy area.
| Client | Lobbying Firm | Amount |
|---|---|---|
| TELEKOM SRBIJA | VALCOUR LLC | $850,000 |
| SONANGOL OPERATIONS DMCC | VALCOUR LLC | $150,000 |
| CONSTELLIUM ROLLED PRODUCTS RAVENSWOOD, LLC | EDWARD C. OLIVARES, LLC | $50,000 |
| EVERYREALM INC. | STINSON LLP | $50,000 |
| CONSTELLIUM MUSCLE SHOALS, LLC | EDWARD C. OLIVARES, LLC | $30,000 |
| INTERNATIONAL SAFETY EQUIPMENT ASSOCIATION | MCALLISTER & QUINN, LLC | $30,000 |
| KUTZTOWN UNIVERSITY | MCALLISTER & QUINN, LLC | $20,000 |
| KOA BIO, LLC | MCALLISTER & QUINN, LLC | $20,000 |
| HEALTHCARE STERILE PROCESSING ASSOCIATION | MCALLISTER & QUINN, LLC | $20,000 |
| CONSTELLIUM U.S. HOLDINGS I | EDWARD C. OLIVARES, LLC | $10,000 |
| TRINIDAD RANCHERIA | HOBBS, STRAUS, DEAN & WALKER, LLP | undisclosed |
| UNION OF OIL AND GAS PRODUCERS RUSSIA | QORVIS HOLDING INC - GEOPOLS | undisclosed |
| IONA UNIVERSITY | MCALLISTER & QUINN, LLC | undisclosed |
| INTERNATIONAL ASSOCIATION OF FIREFIGHTERS, LOCAL NO. 36 | MCALLISTER & QUINN, LLC | undisclosed |
| BANKERS ASSOCIATION FOR FINANCE AND TRADE (FORMERLY KNOWN AS BAFT-IFSA) | BANKERS ASSOCIATION FOR FINANCE AND TRADE (FORMERLY KNOWN AS BAFT-IFSA) | undisclosed |
Source: Senate Lobbying Disclosure Act (LDA) filings, 2026
Top industries funding Andrea Salinas, ranked by total contributions.
Source: OpenSecrets.org (Center for Responsive Politics)
